EyePoint Pharmaceuticals Inc (EYPT)
11.56
-0.31
(-2.61%)
USD |
NASDAQ |
May 08, 16:00
11.95
+0.39
(+3.37%)
After-Hours: 04:45
EyePoint Pharmaceuticals Revenue (TTM): 46.02M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 46.02M |
| September 30, 2023 | 42.52M |
| June 30, 2023 | 37.33M |
| March 31, 2023 | 39.79M |
| December 31, 2022 | 41.40M |
| September 30, 2022 | 42.42M |
| June 30, 2022 | 41.46M |
| March 31, 2022 | 38.91M |
| December 31, 2021 | 36.94M |
| September 30, 2021 | 32.53M |
| June 30, 2021 | 39.16M |
| March 31, 2021 | 34.27M |
| December 31, 2020 | 34.44M |
| September 30, 2020 | 35.94M |
| June 30, 2020 | 22.75M |
| March 31, 2020 | 25.84M |
| December 31, 2019 | 20.36M |
| September 30, 2019 | 12.22M |
| June 30, 2019 | 10.42M |
| March 31, 2019 | 4.141M |
| September 30, 2018 | 3.062M |
| June 30, 2018 | 2.961M |
| March 31, 2018 | 2.947M |
| December 31, 2017 | 2.609M |
| September 30, 2017 | 7.647M |
| Date | Value |
|---|---|
| June 30, 2017 | 7.539M |
| March 31, 2017 | 7.142M |
| December 31, 2016 | 6.876M |
| September 30, 2016 | 1.431M |
| June 30, 2016 | 1.62M |
| March 31, 2016 | 1.725M |
| December 31, 2015 | 1.729M |
| September 30, 2015 | 1.724M |
| June 30, 2015 | 26.56M |
| March 31, 2015 | 26.45M |
| December 31, 2014 | 28.11M |
| September 30, 2014 | 28.18M |
| June 30, 2014 | 3.473M |
| March 31, 2014 | 3.673M |
| December 31, 2013 | 2.194M |
| September 30, 2013 | 2.187M |
| June 30, 2013 | 2.143M |
| March 31, 2013 | 2.35M |
| December 31, 2012 | 2.375M |
| September 30, 2012 | 2.42M |
| June 30, 2012 | 3.526M |
| March 31, 2012 | 6.542M |
| December 31, 2011 | 6.364M |
| September 30, 2011 | 6.148M |
| June 30, 2011 | 4.965M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
10.42M
Minimum
Jun 2019
46.02M
Maximum
Dec 2023
33.41M
Average
36.94M
Median
Dec 2021
Revenue (TTM) Benchmarks
| INVO Bioscience Inc | 3.021M |
| Bio-Path Holdings Inc | -- |
| Ocular Therapeutix Inc | 58.44M |
| Aileron Therapeutics Inc | -- |
| Apellis Pharmaceuticals Inc | 524.07M |